A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart diseaseKyriaki Michailidou, Adam S. Butterworth, Robin Young et al.|UCL Discovery (University College London)|2020Cited by 13
MO802: Genetics Plays a Limited Role in ESA-Hyporesponsiveness and Haemoglobin Outcomes in End-Stage Renal Disease Patients on HaemodialysisSivakumar Gowrisankar, Rubeen Israni, Jennifer L. Aponte et al.|Nephrology Dialysis Transplantation|2022Cited by 0